Axios @axios
The vaccine candidates created by Novavax and AstraZeneca have clinical trial data suggesting they're effective, but have yet to be authorized for use in the U.S. That's left tens of thousands of clinical trial participants in limbo. https://t.co/aJf7l9kZiC — PolitiTweet.org